Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000535 · ClinicalTrials.gov registry record · Phase 3
Trial of Nonpharmacologic Interventions in Elderly (TONE)
A Phase 3 study, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- Phase 3
- Development phase
NCT00000535: Completed Phase 3 study, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
NCT00000535 is a Phase 3 study that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000535, a Phase 3 study, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
To test the efficacy of weight loss and sodium restriction, alone and combined, in maintaining the normotensive state following withdrawal of antihypertensive medications in an elderly cohort. Conducted in collaboration with the National Institute on Aging.
Interventions
- BEHAVIORAL diet, reducing
- BEHAVIORAL diet, sodium-restricted
Trial Details
| Field | Value |
|---|---|
| Start Date | 1992-04 |
| Est. Completion | 1997-03 |
| Phase | Phase 3 |
What the finished NCT00000535 record still lists
NCT00000535 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which diet, reducing is the first listed.
NCT00000535 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000535 about?
NCT00000535 is a clinical study titled "Trial of Nonpharmacologic Interventions in Elderly (TONE)". To test the efficacy of weight loss and sodium restriction, alone and combined, in maintaining the normotensive state following withdrawal of antihypertensive medications in an elderly cohort. Conducted in collaboration with the National Institute on Aging.
What is the current status of trial NCT00000535?
This trial is currently completed. It is a Phase 3 study. The study started on 1992-04. Estimated completion is 1997-03.
What interventions are being tested in trial NCT00000535?
The interventions under investigation include: diet, reducing (BEHAVIORAL), diet, sodium-restricted (BEHAVIORAL).
Who is sponsoring clinical trial NCT00000535?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia